GlassScriptPhysician profile
Esmond K Yen
NPI 1285698100
$1,529.74
in general payments reported to CMS, 2019-2025
19 companies · $444 in 2025
The $444 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $56.98 · 2021: $171 · 2022: $440 · 2023: $91.51 · 2024: $102 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $436.31 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Organon LLC | $243.50 | 2021-2025 | Nexplanon |
| Pfizer INC. | $164.14 | 2022-2025 | |
| Coopersurgical, INC. | $96.91 | 2020-2022 | |
| Therapeuticsmd, INC. | $83.31 | 2021-2022 | |
| Roche Diagnostics Corporation | $82.86 | 2019 | |
| Astellas Pharma US INC | $67.33 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $64.70 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $39.72 | 2025 | Exparel |
| Axsome Therapeutics, INC. | $34.42 | 2025 | Auvelity |
| Covidien LP | $32.33 | 2019 | |
| Lilly USA, LLC | $30.83 | 2022-2025 | Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.94 | 2022 | |
| Merck Sharp & Dohme LLC | $27.56 | 2019-2021 | |
| Abbvie INC. | $25.71 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $23.75 | 2021 | |
| Exeltis, USA INC. | $18.46 | 2025 | Slynd |
| Amgen INC. | $16.23 | 2020 | |
| Evofem Biosciences, INC. | $12.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esmond Yen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.